2019-05-01T16:41:59-05:00 2018-06-30 390859910 BAKER TILLY VIRCHOW KRAUSE LLP 1650 MARKET STREET SUITE 4500 PHILADELPHIA PA 191037341 990 2017-07-01 210672684 CORIELL INSTITUTE FOR MEDICAL RESEARCH INC CORI 8567574828 403 HADDON AVENUE CAMDEN NJ 08103 CONSTANTINE STOIOS CFO 8567574828 2019-04-29 1 JULIUS C GREEN CPA P00350393 2159720701 96.89.178.186 2019-04-29 10:40:16 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 BF90B4BE16E9AE312C0D8383967EBAED4A365E8B 2017 2019-02-21 02:37:17Z CONSTANTINE STOIOS 403 HADDON AVENUE CAMDEN NJ 08103 18886067 0 X WWW.CORIELL.ORG X 1953 NJ GENERATE WORLD CLASS BIOMATERIALS AND CONDUCT GROUNDBREAKING RESEARCH. 13 11 126 19 0 60998 1120670 1302270 17355175 15329456 553453 465293 78821 1004037 19108119 18101056 0 0 0 0 9456187 10233701 0 0 36039 9058161 8466305 18514348 18700006 593771 -598950 31848750 29566205 9521095 7931971 22327655 21634234 X CORIELL'S MISSION IS TO ACCELERATE SCIENTIFIC DISCOVERY BY GENERATING WORLD-CLASS BIOMATERIALS AND CONDUCTING GROUNDBREAKING RESEARCH IN PERSONALIZED MEDICINE AND STEM CELL BIOLOGY. 0 0 13457886 0 15329456 CORIELL INSTITUTE FOR MEDICAL RESEARCH, FOUNDED IN 1953 AND BASED IN CAMDEN, NEW JERSEY, IS AN INDEPENDENT NON-PROFIT RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE HUMAN GENOME. EXPERT STAFF AND PIONEERING PROGRAMS IN THE FIELDS OF PERSONALIZED MEDICINE, CELL BIOLOGY, CYTOGENETICS, GENOTYPING, AND BIOBANKING DRIVE OUR MISSION. THE INSTITUTE MAINTAINS REPOSITORIES FOR CELL LINES AND DNA AND DISTRIBUTES OVER 20,000 BIOMATERIALS ANNUALLY TO RESEARCHERS NATIONALLY AND INTERNATIONALLY.THE CORIELL PERSONALIZED MEDICINE COLLABORATIVE (CPMC) RESEARCH STUDY IS SEEKING TO UNDERSTAND THE USEFULNESS OF GENETIC RISK AND PHARMACOGENOMICS IN CLINICAL DECISION-MAKING AND HEALTHCARE MANAGEMENT.CORIELL HAS A DISTINGUISHED HISTORY IN CELL BIOLOGY, PURSUING CURRENTLY INDUCED PLURIPOTENT STEM (IPS) CELL RESEARCH. THESE POWERFUL CELLS ARE REVOLUTIONIZING THE WAY HUMAN DISEASE IS STUDIED AND HOW DRUGS ARE DEVELOPED. CORIELL OFFERS CUSTOM RESEARCH SERVICES INCLUDING CELL CULTURE, CYTOGENETIC ANALYSES, AND MOLECULAR BIOLOGY. ITS CLIA-CERTIFIED GENOTYPING AND MICROARRAY CENTER OFFERS HIGH-THROUGHPUT DNA ANALYSIS SYSTEMS USING THE PLATFORMS OF TWO LEADING PROVIDERS.ESSENTIAL TO THE INSTITUTE'S SUPPORT OF INTERNATIONAL SCIENTIFIC RESEARCH IS THE CORIELL BIOBANK. FROM THIS RENOWNED CELL BANK, CORIELL MANAGES AND DISTRIBUTES THE WORLD'S MOST DIVERSE COLLECTION OF CELL LINES, DNA, AND OTHER BIOLOGICAL RESOURCES. THE CORIELL BIOBANK PROVIDED SUPPORT TO THE HUMAN GENOME PROJECT, A WORLDWIDE PROGRAM TO MAP THE ENTIRE HUMAN GENOME, AND TO THE INTERNATIONAL HAPMAP PROJECT, A PROJECT PROVIDING AN EFFICIENT TOOL TO IDENTIFY DISEASE-CAUSING GENES.CORIELL'S BIOBANKING OPERATION IS FUNDED BY SEVERAL NATIONAL INSTITUTES OF HEALTH AWARDS. 13457886 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 34 0 1 126 1 1 1 0 0 0 0 0 0 0 0 0 X 13 11 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NJ PA NY CA X DENISE BUSCHER CONTROLLER 8567574846 403 HADDON AVENUE CAMDEN NJ 08103 ROBERT KIEP III CHAIR 1.00 X X 0 0 0 MARC MASER ESQ VICE CHAIR 1.00 X X 0 0 0 MICHAEL F CHRISTMAN PHD PRESIDENT & CEO (UNTIL 12/2017) 40.00 X X 584196 0 22310 ARNAUD BASTIEN MD TRUSTEE 1.00 X 0 0 0 PETER DRISCOLL ESQ TRUSTEE 1.00 X 0 0 0 DAVID FRIEDMAN TRUSTEE 1.00 X 0 0 0 FRANK GIORDANO TRUSTEE 1.00 X 0 0 0 CHARLES LORD TRUSTEE 1.00 X 0 0 0 GEORGE NORCROSS TRUSTEE 1.00 X 0 0 0 JOHN PICCONE TRUSTEE 1.00 X 0 0 0 ALISSA RESCH SECRETARY/PRINCIPAL INVESTIGATOR 40.00 X X 138324 0 17265 ROLAND SCHWARTING TRUSTEE 1.00 X 0 0 0 EDWARD VINER MD TRUSTEE 1.00 X 0 0 0 CONSTANTINE DEAN STOIOS CHIEF FINANCIAL OFFICER/TREASURER 40.00 X 213768 0 32007 KRISTINA GREEN EXEC. DIR, OPER. (UNTIL 2/2017) 40.00 X 17280 0 3798 MARK BELLAFANTE CHIEF INFORMATION OFFICER 40.00 X 201286 0 32746 LEO JOSE DIRECTOR, APPLICATION DEVELOPMENT 40.00 X 137236 0 28284 JOSEPH JARVIS SENIOR RESEARCH SCIENTIST 40.00 X 134366 0 16452 NAHID TURAN PRINCIPAL INVESTIGATOR 40.00 X 134414 0 17628 COURTNEY DIRKS DIRECTOR, PUBLIC RELATIONS 40.00 X 136649 0 25801 STEFAN ZAJIC PRINCIPAL RESEARCH SCIENTIST 40.00 X 134711 0 26152 1832230 0 222443 12 0 1 0 CELLULAR DYNAMICS INTERNATIONAL 603 SCIENCE DRIVE MADISON WI 53711 SCIENTIFIC SERVICES 1046868 1 2695 1037000 262575 5622 1302270 GOVT FEES & CONTRACTS 621500 11657909 11657909 NON-GOVERNMENT REPOSITORY SERVICE 621500 3653447 3653447 INVESTIGATOR DIRECTED SCIENCE 621500 18100 18100 15329456 99486 99486 1000000 150818 671353 113658 328647 37160 365807 365807 LIFE INSURANCE PROCEEDS 900099 1004037 1004037 1004037 18101056 15329456 0 1469330 1019827 1019827 6869245 5715970 1153275 360594 324268 36326 1475666 1013708 461958 508369 385349 123020 162934 162934 202295 202295 44583 44583 1288151 726041 526071 36039 2175334 2113900 61434 2284491 1623740 660751 302600 98376 204224 1928531 1379148 549383 COMM. RECEIPTS HOLD EXP 77386 77386 18700006 13457886 5206081 36039 1200 1200 325696 154044 3893007 4381042 421856 538763 98500 73500 162566 158461 503209 356569 31719335 22981995 9747808 8737340 4391456 3291341 12303452 11873945 31848750 29566205 1894293 1618963 579222 222376 867963 0 5870465 5680376 309152 410256 9521095 7931971 X 8905150 9536880 12605927 11280776 816578 816578 22327655 21634234 31848750 29566205 X -598950 -28943 -65528 X 0 1 X 1 1 1 X 2523357 1298301 1420848 1120670 1302270 7665446 2523357 1298301 1420848 1120670 1302270 7665446 7048 7658398 189689 216365 174582 157614 99486 837736 59315 2223 36 78821 1004037 1144432 9647614 84102751 0.79380 0.86230 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2013 AMOUNT: $ 178. 2014 AMOUNT: $ 2,223. 2015 AMOUNT: $ 36. 2016 AMOUNT: $ 1,435. CAPITAL LEASE REDUCTION - 2013 AMOUNT: $ 59,137. COMMERCIAL RECEIPTS HOLDING REV - 2016 AMOUNT: $ 77,386. LIFE INSURANCE PROCEEDS - 2017 AMOUNT: $ 1,004,037. 44583 44583 18655472 18700055 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 38500 44750 43978 44583 171811 250000 250000 250000 250000 1000000 1500000 4391456 11468 388417 1500000 3291341 5769781 8507 913168 2300000 4391456 7717138 1237 -448594 1500000 5769781 7634237 6339 76562 7717138 6427603 208295 998339 7634237 0.20660 0.24810 0.54530 0 0 245000 245000 14444124 9728853 4715271 1746667 1450387 296280 15283544 11802755 3480789 8737340 NEW JERSEY CORD BLOOD BANK 4675500 USE OF RESEARCH FACILITY 6541745 SPLIT-INTEREST AGREEMENTS 652515 OTHER MISCELLANEOUS ASSETS 4185 11873945 ADVANCES ON HAND 133946 DERIVATIVE FINANCIAL INSTRUMENT 115 HOLDING ACCOUNTS 19724 OVER-RECOVERY INDIRECT COSTS 256471 410256 X 19544976 -28943 652275 820588 1443920 18101056 0 18101056 20639683 652275 1364788 2017063 18622620 77386 77386 18700006 PART V, LINE 4: THE INSTITUTE'S ENDOWMENT FUNDS ARE USED TO SUPPORT THE SHORT AND LONG TERM GOALS OF THE INSTITUTE. THE INSTITUTE DREW $1,500,000 OF FUNDS FROM THE ENDOWMENT DURING THE YEAR ENDING JUNE 30, 2018. PART X, LINE 2: THE INSTITUTE ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE-LIKELY-THAN-NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2018 AND 2017. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 26,292. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -104,001. CHANGE IN VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 12,181. CORIELL LIFE SCIENCE REVENUE 1,128,029. CORIELL LIFE SCIENCES NON-CONTROLLING INTERESTS -164,527. COMMERCIAL RECEIPTS HOLDING EXP -77,386. PART XII, LINE 2D - OTHER ADJUSTMENTS: CORIELL LIFE SCIENCE EXPENSES 1,364,788. PART XII, LINE 4B - OTHER ADJUSTMENTS: COMMERCIAL RECEIPTS HOLDING EXP 77,386. X X X X 0 0 0 0 0 0 0 1 0 MICHAEL F CHRISTMAN PHD PRESIDENT & CEO (UNTIL 12/2017) 493196 0 91000 0 0 0 18900 0 3410 0 606506 0 0 0 ALISSA RESCH SECRETARY/PRINCIPAL INVESTIGATOR 133324 0 5000 0 0 0 9715 0 7550 0 155589 0 0 0 CONSTANTINE DEAN STOIOS CHIEF FINANCIAL OFFICER/TREASURER 188768 0 25000 0 0 0 15754 0 16253 0 245775 0 0 0 MARK BELLAFANTE CHIEF INFORMATION OFFICER 177286 0 24000 0 0 0 14630 0 18116 0 234032 0 0 0 LEO JOSE DIRECTOR, APPLICATION DEVELOPMENT 137236 0 0 0 0 0 10338 0 17946 0 165520 0 0 0 JOSEPH JARVIS SENIOR RESEARCH SCIENTIST 114366 0 20000 0 0 0 9391 0 7061 0 150818 0 0 0 NAHID TURAN PRINCIPAL INVESTIGATOR 129414 0 5000 0 0 0 9538 0 8090 0 152042 0 0 0 COURTNEY DIRKS DIRECTOR, PUBLIC RELATIONS 124149 0 12500 0 0 0 9328 0 16473 0 162450 0 0 0 STEFAN ZAJIC PRINCIPAL RESEARCH SCIENTIST 129711 0 5000 0 0 0 10045 0 16107 0 160863 0 0 0 PART I, LINE 7 THE COMPENSATION COMMITTEE DETERMINES BONUSES FOR OFFICERS AND KEY EMPLOYEES BASED UPON VARIOUS PERFORMANCE CRITERIA. PERFORMANCE CRITERIA ARE BASED ON VARIOUS OBJECTIVES, SOME OF WHICH ARE BASED ON BUSINESS/ FINANCIAL GOALS. OVERALL, THE PRIMARY OBJECTIVES ARE OPERATIONAL IN NATURE WITH CONSIDERATION GIVEN TO FINANCIAL OUTCOMES. M CHRISTMAN PHD TRUSTEE/PRESIDENT AND CEO PURCHASE PROPERTY X 250000 73500 0 1 1 73500 FORM 990, PART VI, SECTION A, LINE 1 THERE ARE 11 BOARD MEMBERS ON THE EXECUTIVE COMMITTEE. WITH THE EXCEPTION OF THE PRESIDENT AND CEO, THE OTHER BOARD MEMBERS OF THE EXECUTIVE COMMITTEE ARE NON-EMPLOYED VOLUNTARY BOARD MEMBERS. THE EXECUTIVE COMMITTEE MAY ACT ON BEHALF OF THE BOARD OF TRUSTEES WHEN THE BOARD IS NOT IN SESSION. FORM 990, PART VI, SECTION A, LINE 2 CORIELL LIFE SCIENCES, INC., A SPIN-OFF FOR-PROFIT ORGANIZATION FROM CORIELL INSTITUTE FOR MEDICAL RESEARCH, WAS PRIMARILY CONTROLLED BY THE CORIELL INSTITUTE FOR MEDICAL RESEARCH DURING FY 2018 (6/30/18). DURING FY 2018 (6/30/18), CORIELL LIFE SCIENCES, INC. DID GENERATE REVENUE, BUT RESULTED IN A NET OPERATING LOSS. FORM 990, PART VI, SECTION B, LINE 11B THE CONTROLLER INITIALLY PERFORMS A THOROUGH REVIEW OF THE FORM 990 AND THEN THE CFO PROVIDES A SECOND REVIEW. ONCE APPROVED AFTER INTERNAL REVIEW, THE CHAIR OF THE AUDIT COMMITTEE REVIEWS THE FORM 990 AND PRESENTS ITS CONTENTS TO MEMBERS OF THE AUDIT AND EXECUTIVE COMMITTEES. THE FORM IS DISTRIBUTED TO ALL CORIELL TRUSTEES BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CEO ANNUALLY DISTRIBUTES THE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH MEMBER OF THE BOARD OF TRUSTEES. EACH TRUSTEE MUST COMPLETE AND RETURN THE ANNUAL DISCLOSURE STATEMENT TO THE CEO ON A TIMELY BASIS. HE OR SHE MUST TIMELY INFORM THE CEO AND/OR THE COMMITTEE OF ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST OR OF ANY SITUATION WHICH MIGHT LEAD TO THE APPEARANCE OF A CONFLICT OF INTEREST. IN ADDITION, THE CHIEF FINANCIAL OFFICER (CFO) ANNUALLY DISTRIBUTES A COPY OF THE EMPLOYEE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH OFFICER, EXECUTIVE, AND APPROPRIATE EMPLOYEE. THESE EMPLOYEES ARE REQUIRED TO SUBMIT THE COMPLETED DISCLOSURE STATEMENT TO THE CFO AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST. REPORTED CONFLICTS OF INTEREST ARE SHARED WITH THE EXECUTIVE COMMITTEE. ANY BOARD MEMBER WHO HAS A CONFLICT OF INTEREST IS EXCLUDED FROM VOTING ON ANY ISSUE INVOLVING THE CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 USING COMPARABILITY DATA SOURCED FROM AN INDEPENDENT ORGANIZATION, A BOARD OF TRUSTEES' COMPENSATION COMMITTEE REVIEWS THE PERFORMANCE AND ESTABLISHES THE ANNUAL COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. COMPENSATION DECISIONS ARE DETERMINED BY TAKING INTO CONSIDERATION THE FAIR MARKET RANGE FOR THE INDUSTRY. ALL COMMITTEE DISCUSSIONS ARE DOCUMENTED IN BOARD MINUTES. THE PRESIDENT DETERMINES THE COMPENSATION ANNUALLY FOR ALL OTHER EMPLOYEES, INCLUDING OFFICERS AND KEY EMPLOYEES, BASED ON PERFORMANCE APPRAISALS AND REVIEWS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 26,292. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -104,001. CHANGE IN FAIR VALUE OF DERIVATIVE FINANCIAL INSTRUMENT 12,181. CORIELL LIFE SCIENCE REVENUE 1,128,029. CORIELL LIFE SCIENCES NON-CONTROLLING INTERESTS -164,527. CORIELL LIFE SCIENCE EXPENSES -1,364,788. NET ASSET VALUE - CORIELL LIFE SCIENCES 401,286. CORIELL LIFE SCIENCES 403 HADDON AVENUE CAMDEN NJ 08103 461794812 GENETIC DATA STORAGE AND INTERPRETATION DE CORIELL INSTITUTE FOR MEDICAL RESEARCH C -236759 843797 0.67000 1 0 0 0 1 0 0 0 0 0 0 1 0 1 1 1 0 1 0 0 CORIELL LIFE SCIENCES D 2609539 COST